These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 25868666

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Alkaptonuria is a novel human secondary amyloidogenic disease.
    Millucci L, Spreafico A, Tinti L, Braconi D, Ghezzi L, Paccagnini E, Bernardini G, Amato L, Laschi M, Selvi E, Galeazzi M, Mannoni A, Benucci M, Lupetti P, Chellini F, Orlandini M, Santucci A.
    Biochim Biophys Acta; 2012 Nov; 1822(11):1682-91. PubMed ID: 22850426
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Homogentisic acid induces aggregation and fibrillation of amyloidogenic proteins.
    Braconi D, Millucci L, Bernini A, Spiga O, Lupetti P, Marzocchi B, Niccolai N, Bernardini G, Santucci A.
    Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):135-146. PubMed ID: 27865997
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Amyloidosis, inflammation, and oxidative stress in the heart of an alkaptonuric patient.
    Millucci L, Ghezzi L, Paccagnini E, Giorgetti G, Viti C, Braconi D, Laschi M, Geminiani M, Soldani P, Lupetti P, Orlandini M, Benvenuti C, Perfetto F, Spreafico A, Bernardini G, Santucci A.
    Mediators Inflamm; 2014 Feb; 2014():258471. PubMed ID: 24876668
    [Abstract] [Full Text] [Related]

  • 8. Ochronotic pigmentation is caused by homogentisic acid and is the key event in alkaptonuria leading to the destructive consequences of the disease-A review.
    Ranganath LR, Norman BP, Gallagher JA.
    J Inherit Metab Dis; 2019 Sep; 42(5):776-792. PubMed ID: 31282009
    [Abstract] [Full Text] [Related]

  • 9. A novel ex vivo organotypic culture model of alkaptonuria-ochronosis.
    Tinti L, Spreafico A, Chellini F, Galeazzi M, Santucci A.
    Clin Exp Rheumatol; 2011 Sep; 29(4):693-6. PubMed ID: 21813063
    [Abstract] [Full Text] [Related]

  • 10. Oxidative stress and mechanisms of ochronosis in alkaptonuria.
    Braconi D, Millucci L, Bernardini G, Santucci A.
    Free Radic Biol Med; 2015 Nov; 88(Pt A):70-80. PubMed ID: 25733348
    [Abstract] [Full Text] [Related]

  • 11. Homogentisic acid induces morphological and mechanical aberration of ochronotic cartilage in alkaptonuria.
    Bernardini G, Leone G, Millucci L, Consumi M, Braconi D, Spiga O, Galderisi S, Marzocchi B, Viti C, Giorgetti G, Lupetti P, Magnani A, Santucci A.
    J Cell Physiol; 2019 May; 234(5):6696-6708. PubMed ID: 30341892
    [Abstract] [Full Text] [Related]

  • 12. Homogentisic acid induces autophagy alterations leading to chondroptosis in human chondrocytes: Implications in Alkaptonuria.
    Galderisi S, Milella MS, Rossi M, Cicaloni V, Rossi R, Giustarini D, Spiga O, Tinti L, Salvini L, Tinti C, Braconi D, Millucci L, Lupetti P, Prischi F, Bernardini G, Santucci A.
    Arch Biochem Biophys; 2022 Mar 15; 717():109137. PubMed ID: 35090868
    [Abstract] [Full Text] [Related]

  • 13. Redox-proteomics of the effects of homogentisic acid in an in vitro human serum model of alkaptonuric ochronosis.
    Braconi D, Bianchini C, Bernardini G, Laschi M, Millucci L, Spreafico A, Santucci A.
    J Inherit Metab Dis; 2011 Dec 15; 34(6):1163-76. PubMed ID: 21874298
    [Abstract] [Full Text] [Related]

  • 14. Cytoskeleton Aberrations in Alkaptonuric Chondrocytes.
    Geminiani M, Gambassi S, Millucci L, Lupetti P, Collodel G, Mazzi L, Frediani B, Braconi D, Marzocchi B, Laschi M, Bernardini G, Santucci A.
    J Cell Physiol; 2017 Jul 15; 232(7):1728-1738. PubMed ID: 27454006
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Homogentisate 1,2 dioxygenase is expressed in brain: implications in alkaptonuria.
    Bernardini G, Laschi M, Geminiani M, Braconi D, Vannuccini E, Lupetti P, Manetti F, Millucci L, Santucci A.
    J Inherit Metab Dis; 2015 Sep 15; 38(5):807-14. PubMed ID: 25762405
    [Abstract] [Full Text] [Related]

  • 18. Histological and Ultrastructural Characterization of Alkaptonuric Tissues.
    Millucci L, Bernardini G, Spreafico A, Orlandini M, Braconi D, Laschi M, Geminiani M, Lupetti P, Giorgetti G, Viti C, Frediani B, Marzocchi B, Santucci A.
    Calcif Tissue Int; 2017 Jul 15; 101(1):50-64. PubMed ID: 28271171
    [Abstract] [Full Text] [Related]

  • 19. Diagnosis of secondary amyloidosis in alkaptonuria.
    Millucci L, Ghezzi L, Bernardini G, Braconi D, Lupetti P, Perfetto F, Orlandini M, Santucci A.
    Diagn Pathol; 2014 Sep 26; 9():185. PubMed ID: 25567001
    [Abstract] [Full Text] [Related]

  • 20. Antioxidants inhibit SAA formation and pro-inflammatory cytokine release in a human cell model of alkaptonuria.
    Spreafico A, Millucci L, Ghezzi L, Geminiani M, Braconi D, Amato L, Chellini F, Frediani B, Moretti E, Collodel G, Bernardini G, Santucci A.
    Rheumatology (Oxford); 2013 Sep 26; 52(9):1667-73. PubMed ID: 23704321
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.